Literature DB >> 30561167

First line treatment of aplastic anemia with thymoglobuline in Europe and Asia: Outcome of 955 patients treated 2001-2012.

Andrea Bacigalupo1, Rosi Oneto1, Hubert Schrezenmeier2, Britta Hochsmann2, Carlo Dufour3, Seiji Kojima4, Xiaofan Zhu5, Xiaojuan Chen5, Surapol Issaragrisil6, Suporn Chuncharunee6, Dae Chul Jeong7, Sabrina Giammarco1, Maria Teresa Van Lint8, Yizhou Zheng9, Carlos Vallejo10.   

Abstract

Entities:  

Year:  2018        PMID： 30561167      PMCID： PMC6886037          DOI： 10.1002/ajh.25138

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  1 in total

1.  Optimizing conditioning regimen with low-dose irradiation or busulfan enables the outcome of transplantation from a 6-7/8 HLA-matched donor comparable to that from an 8/8 HLA-matched unrelated donor in severe aplastic anemia patients under 40 years.

Authors:  Xia Qin; Yi-Ping Zhu; Cheng-Juan Luo; Ming Zhou; Ke Huang; Chun Chen; Wei-Ping Zhang; Yuan Sun; Rong-Mu Luo; Xiang-Feng Tang; Ting Yang; Xian-Min Song; Shao-Yan Hu; Zi-Min Sun; Jiong Hu; Shun-Qing Wang; Jing Chen
Journal:  Ann Hematol       Date:  2021-05-14       Impact factor: 3.673
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.